Geography includes Southern NV, Southern CA (to Sacramento), AK, and HI. 

EVERSANA has partnered with Sun Pharma for a field-based team within their Cutaneous Oncology Business Unit. The Cutaneous Oncology CNE is a licensed nurse with oncology and/ or immunology expertise who will support the upcoming U.S. launch of UNLOXCYT (cosibelimab), a novel PD-L1 inhibitor for advanced cutaneous squamous cell carcinoma (cSCC). The field based CNE will serve as a clinical and educational resource to Infusion Center Care Teams in support of UNLOXCYT (cosibelimab).

This is a field-based role within the Cutaneous Oncology Business Unit designed to educate, equip, and empower healthcare professionals and infusion site personnel on the safe, effective, and confident use of UNLOXCYT.

In this role, the CNE will:

• Serve a the clinical on-label subject matter expert regarding UNLOXCYT’s multifaceted mechanism of action, administ...